Emerging pathogens and their implications for the blood supply and transfusion transmitted infections

British Journal of Haematology - Tập 159 Số 2 - Trang 135-142 - 2012
Roger Y. Dodd1
1Research and Development, American Red Cross Holland Laboratory Rockville MD USA

Tóm tắt

SummaryThe threat of infection by conventional transfusion‐transmitted agents has been essentially eliminated from the blood supply in developed countries, thus focusing attention on the potential risk from emerging infections. Over recent years, actions have been taken to manage a number of such risks to blood safety. These illustrate the inherent variability of the agents concerned and of the measures needed to define and control the risk.

Từ khóa


Tài liệu tham khảo

10.1126/science.334.6063.1636-a

10.1111/j.1537‐2995.2011.03554.x

10.1111/j.1537-2995.2010.02699.x

10.1046/j.1537-2995.2002.00167.x

10.1111/j.1365-3148.2006.00652.x

10.1111/j.1537-2995.2008.01646.x

10.1016/j.tmrv.2005.08.005

10.1016/j.tmrv.2006.11.001

10.1111/j.1537‐2995.2012.03581.x

10.1056/NEJMp078013

Chuang W.W., 2008, Review of dengue fever cases in Hong Kong during 1998‐2005, Hong Kong Medical Journal, 14, 170

10.1111/j.1537-2995.2011.03450.x

10.1111/j.1537-2995.2006.00865.x

10.1016/S0140-6736(07)61687-0

10.1111/j.1365-2990.2012.01265.x

10.7326/0003-4819-155-8-201110180-00362

10.1111/j.1423-0410.2006.00833.x

Hoek W., 2010, Q fever in the Netherlands: an update on the epidemiology and control measures, European Surveillance, 15

10.1111/j.1537-2995.2011.03250.x

10.1128/CMR.00022-10

10.1128/MMBR.00007-10

Liumbruno G.M., 2008, The Chikungunya epidemic in Italy and its repercussion on the blood system, Blood Transfusion, 6, 199

10.1073/pnas.1006901107

10.1073/pnas.1119641109

10.1126/science.1179052

10.1182/blood-2011-02-335901

10.1016/S1473-3099(08)70256-1

10.1056/NEJMoa073785

10.1126/science.1205292

10.1056/NEJMoa030969

10.1038/nm1143

10.1056/NEJMp048261

10.1016/S1473-3099(05)70052-9

10.1111/j.1537-2995.2009.02111.x

10.1111/j.1537-2995.2008.01910.x

10.1126/science.1213841

10.1136/bmj.324.7352.1479

10.1056/NEJMoa044333

10.1111/j.1537-2995.2009.02279.x

10.1111/j.1537‐2995.2012.03566.x

10.1056/NEJMc0708673

10.1371/journal.ppat.0030201

United Kingdom Health Protection Agency. (2009)vCJD abnormal prion protein found in a patient with haemophilia at post mortem. Evidence of infection with the agent (abnormal prion protein) that causes variant Creutzfeldt‐Jakob Disease (vCJD) has been found at post mortem in the spleen of a person with haemophilia. Press Release 16 Feb 2009.http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1234859690542?p=1231252394302accessed August 2010

10.1371/journal.ppat.0020025

10.1056/NEJMra1202018

10.1128/MMBR.00033-07

10.1038/nm1150

10.1001/archinte.158.19.2149

10.1056/NEJMra030840

10.1111/j.1537-2995.2012.03612.x

Thông tin
Thông tin xuất bản

British Journal of Haematology

Tập 159 Số 2

135-142

Thông tin tác giả